Stockreport

Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treat [Read more]